Changeflow GovPing Banking & Finance BaFin Fines aap Implantate AG €158,000 for Disc...
Priority review Enforcement Amended Final

BaFin Fines aap Implantate AG €158,000 for Disclosure Violation

Favicon for www.bafin.de BaFin News
Filed March 18th, 2026
Detected March 19th, 2026
Email

Summary

Germany's BaFin has fined aap Implantate AG €158,000 for violating securities trading laws. The company failed to properly announce the public availability of its half-year financial report for 2024, including the specific website address. The company has the right to appeal the decision.

What changed

BaFin, Germany's financial supervisory authority, has imposed a fine of €158,000 on aap Implantate AG for a violation of Section 115(1) Satz 2 of the German Securities Trading Act (WpHG). The violation specifically relates to the company's failure to publish a timely announcement regarding the public accessibility of its half-year financial report for the 2024 fiscal year, including the relevant internet address where the report was made available in addition to its availability in the company register.

This enforcement action highlights the critical importance of timely and accurate disclosure of financial information for publicly traded companies. Compliance officers should ensure that all required financial reports are made publicly available as mandated by law and that the necessary announcements, including website details, are disseminated promptly. Failure to comply can result in significant financial penalties. Aap Implantate AG has the option to appeal this fine.

What to do next

  1. Review disclosure procedures for financial reports
  2. Ensure timely publication and announcement of financial report availability
  3. Verify compliance with WpHG disclosure requirements

Penalties

€158,000

Source document (simplified)

Erscheinung: 18.03.2026 | Thema Maßnahmen Bekanntmachung

Die Finanzaufsicht BaFin hat am 3. März 2026 eine Geldbuße in Höhe von 158.000 Euro gegen die aap Implantate AG festgesetzt.

Der Sanktion lag ein Verstoß gegen § 115 Absatz 1 Satz 2 Wertpapierhandelsgesetz (WpHG) zugrunde. Die aap Implantate AG hatte keine Bekanntmachung darüber veröffentlicht, ab welchem Zeitpunkt und unter welcher Internetadresse der Halbjahresfinanzbericht für das Geschäftsjahr 2024 zusätzlich zu seiner Verfügbarkeit im Unternehmensregister öffentlich zugänglich war.

Das Unternehmen kann gegen den Bußgeldbescheid Einspruch einlegen.

Zur Meldung wechseln

Fanden Sie den Beitrag hilfreich?

Wir freuen uns über Ihr Feedback Es hilft uns, die Webseite kontinuierlich zu verbessern und aktuell zu halten. Bei Fragen, für deren Beantwortung wir Sie kontaktieren sollen, nutzen Sie bitte unser Kontaktformular.

Wir freuen uns über Ihr Feedback hilfreich weniger hilfreich Kommentar (max. 1000 Zeichen):

Named provisions

§ 115 Absatz 1 Satz 2 Wertpapierhandelsgesetz (WpHG)

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
BaFin
Filed
March 18th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Meldung 2026_03_18_aap_Implantate_AG

Who this affects

Applies to
Public companies
Industry sector
3345 Medical Device Manufacturing
Activity scope
Financial Reporting Disclosure
Geographic scope
Germany DE

Taxonomy

Primary area
Securities
Operational domain
Compliance
Topics
Corporate Governance Financial Reporting

Get Banking & Finance alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when BaFin News publishes new changes.

Free. Unsubscribe anytime.